contributing lecturers · initiative study (aris), which evaluates the natural course of early amd....

16
2019 CONTINUING EDUCATION PROGRAM June 14, 15 & 16 CONTRIBUTING LECTURERS

Upload: others

Post on 22-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

2019 CONTINUING EDUCATION PROGRAM

June 14, 15 & 16

CONTRIBUTING LECTURERS

Page 2: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Emily Chew, MD Emily Chew is the Director of the Division of Epidemiology and Clinical Applications (DECA), at the National Eye Institute, the National Institutes of Health in Bethesda, Maryland. She is also the Chief of the Clinical Trials Branch. Emily received her medical degree and her ophthalmology training at the U. of Toronto, School of Medicine, in Toronto, Canada. She completed her fellowship in Medical Retina at the Wilmer Eye Institute, the Johns Hopkins Medical Institutes and the U. of Nijmegen, the Netherlands Her research interest includes designing and conducting phase I/II clinical trials and epidemiologic studies in chronic retinovascular diseases such as age-related macular degeneration, diabetic retinopathy, the leading causes of blindness in the US. She also studies rare diseases such as ocular manifestation of von Hippel-Lindau Disease and others. She works extensively in large multi-centered trials headed by the staff of DECA including the diabetic studies, the Age-Related Eye Disease Study and the Age-Related Eye Disease Study 2, which she chairs. She also chairs the Actions to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study in participants with type 2 diabetes, working in collaboration with NHLBI and NIDDK colleagues. Emily Chew is the director of the clinical program in the Macular Telangiectasia Project (Mac Tel Project) which is an international study conducted in 22 clinics in 7 countries along with four basic science laboratories. She chairs the current international study, known as the AMD Ryan Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep learning on the detection and progression of age-related macular degeneration. Along with the team in the Clinical Trials Branch, she provides the clinical training as well as education in conducting clinical trials to the medical students and the fellows training in medical retina. She served on the editorial board of Investigative Ophthalmology and Vision, Ophthalmology, and Retina journals. And had served as the editor of the Transactions of the American Ophthalmological Society. Emily Chew has received recognition for her research and her mentorship from the American Academy of Ophthalmology, other professional societies in her field and from NIH.

Page 3: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

John G. Flanagan, PhD, DSc(hon), FCOptom, FAAO, FARVO

John G. Flanagan is the Dean and Professor at the School of Optometry and Vision Science Program, University of California, Berkeley. Until May 2014 he was Professor at the School of Optometry and Vision Science, University of Waterloo and in the Department of Ophthalmology and Vision Sciences, University of Toronto. He was Director of the Glaucoma Research Unit, Toronto Western Research Institute and a Senior Scientist at the Toronto Western Hospital, University Health Network. He graduated in Optometry and Vision Sciences from Aston University, Birmingham, UK in 1980, where he later earned his PhD in 1985. He has held continuous federal research funding for over 28 years (MRC/CIHR/CHRP/ORF) with additional research funding from the American Health Assistance Foundation, the Glaucoma Research Society of Canada and the Glaucoma Research Foundation. He has supervised 45 graduate students and has authored over 170 peer-reviewed publications. In addition he has 10 book chapters, 4 books and given numerous invited lectures to both professional and academic audiences around the world. His research interests include basic mechanisms of human glaucoma (glial cell activation, neuroprotection), ocular imaging, clinical psychophysics, 24-hour intraocular pressure, ocular blood flow and studies of vascular reactivity. Awards include Certificate of Merit for Research Excellence, Glaucoma Research Society of Canada; Clair Bobier Lecture, University of Waterloo; Springer Lecture, University of Alabama; the Glenn A Fry Award from the American Academy of Optometry; Outstanding Performance Award, University of Waterloo (2004 & 2013); Institute of Medical Science Mel Silverman Mentorship Award, Faculty of Medicine, University of Toronto, 2011; and the Dario Lorenzetti Lecture, McGill Ophthalmology, 2013. He was a plenary lecturer at the 2003 AAO meeting, and was appointed as faculty for the inaugural World Glaucoma Congress in 2005 and the each subsequent WGC meeting. He was a founding member of the Optometric Glaucoma Society; Program Chair from 2002 to 2007, and President from 2007 to 2012. He is also a member of the American Glaucoma Society, Association for Research in Vision and Ophthalmology, International Society for Eye Research, American Academy of Optometry, Canadian Ophthalmological Society and Canadian Association of Optometrists. In 2008-2014 he was Chair of the Clinical Research Ethics Committee at the University of Waterloo. He has also served as a Governor and Senator at the University of Waterloo, and was a member of the Senate Executive Committee. In 2015 he was awarded a life fellowship of the British College of Optometrists. In 2016 he received a DSc honoris causa from alma mater Aston University, and fellowship of the Association for Research in Vision and Ophthalmology (FARVO).

Page 4: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Lacey Haines, BSc, OD, FIACLE Lacey Haines graduated from Memorial University of Newfoundland in 2008 with a Bachelor of Science degree in Biology (major) and Math (minor). She completed her Doctor of Optometry Degree at the University of Waterloo School of Optometry and Vision Science (WOVS) in 2012. Since graduating, Lacey has completed residency training in Cornea and Contact Lenses and is now pursuing a PhD in Vision Science at WOVS. She joined the WOVS faculty as an Assistant Clinical Professor in 2016. She is also a fellow of the International Association of Contact Lens Educators. Clinical and research interests include anterior segment imaging, specialty contact lens fitting, keratoectasia and management of contact lens complications.

Page 5: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Patricia Hrynchak, OD, FAAO Patricia Hrynchak is a Clinical Professor at the School of Optometry and Vision Science at the University of Waterloo. She graduated with her optometry degree from the School of Optometry and Vision Science at the University of Waterloo and obtained her MSc(Health Practitioner Teacher Education) from the University of Toronto. Her clinical focus is in Primary Care and she has worked extensively in Low Vision. Her classroom teaching includes Case Analysis and Clinical Techniques. She is the recipient of multiple teaching awards. Her research interests includes the scholarship of teaching and learning, public health and refractive development of the human visual system.

Page 6: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Alex Hynes, OD, School of Optometry & Vision Science, University of Waterloo

Alex Hynes completed his Doctor of Optometry degree in 2017 followed by a one-year clinical residency in Ocular Disease and Glaucoma at the University of Waterloo in 2017-18. He completed his American Academy of Optometry Fellowship in 2018. After his residency Alex was hired by local ophthalmologist Dr. Chryssa McAlister where he has an interest in seeing patients with glaucoma, dry eye, in need of cataract surgery, and presenting with ocular emergencies. He also works as a part time clinical instructor at the University of Waterloo in the ocular health and primary care clinics. Alex has helped instruct several clinical labs including anterior, posterior segment, and ocular health techniques.

Page 7: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Lyndon Jones, PhD, DSc, FCAHS, FCOptom, FAAO Lyndon Jones is a Professor at the School of Optometry and Vision Science, University Research Chair and Director of the Centre for Ocular Research & Education (CORE) at the University of Waterloo. His research interests primarily focus on the interaction of novel and existing contact lens materials with the ocular environment, dry eye and the development of novel materials for ocular drug delivery. He has authored over 400 refereed and professional papers, one text-book and given over 1000 invited lectures at conferences worldwide, in over 40 countries.

Page 8: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Shamroze Khan, OD

Page 9: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Derek MacDonald, OD, FAAO

Dr. Derek MacDonald graduated from the University of Waterloo School of Optometry in 1992, and began full-scope private practice in Waterloo with special interest in ocular and systemic disease. He served a two-year term as OAO President between 2005 and 2007, was elected to the Council of the College of Optometrists of Ontario in 2010 and 2012, and retired in 2016. Dr. MacDonald is a founding member of the Eye Health Council of Ontario, a Fellow of the American Academy of Optometry (where he sits on the AAO International Admittance Committee), and a member of both the Optometric Glaucoma and Optometric Retina Societies. His research, lecturing, and writing are primarily focused on glaucoma, retinal vascular disease, and ophthalmic imaging.

Page 10: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Sarah MacIver, OD

Page 11: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Richard L. Maharaj OD, FAAO

Dr. Richard Maharaj completed his Doctor of Optometry degree at the University of

Waterloo School of Optometry in 2003, and Fellowship of the American Academy of

Optometry in 2012. He is lead optometrist at Humber River Regional Hospital -

York/Finch Eye Associates - an integrated medical eye clinic. Dr. Maharaj has a special

interest in dry eye disease, glaucoma and disease of the retina. He is a clinical adjunct

associate for the University of Waterloo College of Optometry. He is currently a

professional affairs consultant for Johnson and Johnson Vision Care, and has

consulted for other companies like Allergan, TearScience, and CIBA. He is a published

respected national speaker in eye education on diseases and diagnostics of cornea,

retina and meibomian gland dysfunction. His primary research is in non-surgical

treatments of the eyelid and periocular glands. In 2014 he launched POHxTM

(Periocular Hygenix) which is a line of preventative and therapeutic treatments for

patients with dry eye disease.. He is an active member of the Ontario Association of

Optometrists, Canadian Association of Optometrists, American Academy of

Optometrists and the College of Optometrists of Ontario.

Page 12: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Victor Perez, MD, Duke Eye Center, Durham, NC

Page 13: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

C. L. Prokopich, OD

Page 14: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Vishakha Thakrar, OD

Page 15: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Faran Vafaie, OD, MSc, BSc

Dr. Vafaie is an optometrist practicing with a special focus on ocular disease management. He received his optometry degree from the University of Waterloo as well as his Masters of Science in Biochemistry at Western University. His special interest is in glaucoma as well as perisurgical care. He is the lead OD of the EyeLABS Glaucoma program where he also offers time as an adjunct clinical instructor for fourth year Waterloo Optometry students on their ocular disease rotations. He has also spent the past two years developing a collaborative comanagement model at the Prism Eye Institute, working hand in hand with glaucoma specialists and general ophthalmologists in providing better access to care for patients.

Page 16: CONTRIBUTING LECTURERS · Initiative Study (ARIS), which evaluates the natural course of early AMD. Finally, she collaborates with colleagues at NLM/NIH utilizing of artificial intelligence/deep

Yue (Evelyn) Zhang, OD, BSc Dr. Yue Evelyn Zhang completed her Bachelor of Science and Doctor of Optometry degrees in 2018 at the University of Waterloo. She is currently completing a residency in Cornea and Contact Lens at the University of Waterloo School of Optometry and Vision Science. Her clinical and research interests are in specialty contact lens fitting, myopia control, and keratoconus.